Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Prevention of SIPE
NCT03686813Phase 2Completed
- Sponsor
- Duke University
- Start
- Jul 2019
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ASP-001 in pulmonary edema, sponsored by Duke University. Started Jul 2019; status: completed.
02
Drugs
ASP-001
03
Conditions
pulmonary edema
Beyond the preview
Go deeper on NCT03686813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03686813.